Dividing Abilify Dose
Links shared publicly online about this topic
Comments of using Wellbutrin Xl, Abilify, Concerta (study 6192781) - eHealthMe.com
ehealthme.com — “My son has been taking high doses of Concerta XR 3 36mg pills every morning for 5-10 years and he was recently diagnosed with Lesions on his brain. He was having memory loss and losing IQ. Could this medicine have caused a stroke at such high doses?” View full resource at ehealthme.com
Most Recently Shared on March 26, 2012 at 5:36 am By:
My son has been taking high doses of Concerta XR 3 36mg pills every morning for 5-10 years and he was recently http://t.co/wWVROaRr
A placebo-controlled, fixed-dose study of aripipra... [J Am Acad Child Adolesc Psychiatry. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on October 3, 2009 at 2:38 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Aripiprazole (Abilify) reduces irritability in adolescents with autism in clinical trial. http://ow.ly/swv6
OpEdNews - Article: Tracking the American Epidemic of Mental Illness - Part II
opednews.com — “A fortune can be made from these life-long antipsychotic customers. In April 2010, the price for one box of Invega, at a middle dose, was $1,373 at DrugStore.com. Risperdal went for $788 per 90 pills. The cost was $1,395 for 100 tablets of Abilify. Seroquel cost $997 per 100. One-hundred capsules of Geodon sold for $918 and Zyprexa cost $1,523 for a hundred 10mg pills.” View full resource at opednews.com
Most Recently Shared on June 3, 2010 at 5:38 am By:
Peter H Brown Doctor and Psychologist
Tracking the American Epidemic of Mental Illness - Part II http://bit.ly/cQtglM #psychosis #schizo
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ALKS 9070, a proprietary Alkermes molecule for the treatment of schizophrenia, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY® for the treatment of a number of central nervo” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 6:00 pm By:
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia: Alkermes, Inc... http://bit.ly/kd2y2o
BBC News - Splitting tablets 'may mean patients take wrong doses'
bbc.co.uk — “Patients who take their medication from tablets which are divided up could be at risk of taking incorrect doses a study suggests.” View full resource at bbc.co.uk
Most Recently Shared on January 8, 2011 at 3:34 pm By:
Nardo Manaloto Health Professional
Splitting tablets 'may mean patients take wrong doses' (a chance to #innovate current system) http://flne.ws/26335368 on Fluent News
Baking Soda May Be Key Ingredient for Kidney Patients
realage.com — “Baking Soda May Be Key Ingredient for Kidney Patients” View full resource at realage.com
Most Recently Shared on July 17, 2009 at 5:45 pm By:
Study shows a dose of baking soda a day may slow progression of chronic kidney disease: http://tinyurl.com/nd85rt
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on December 1, 2009 at 4:27 pm By:
Multi-center US Clinical Trial, High-Dose combo chemo + Rituxan for HIV-related Burkitt's Lymphoma http://bit.ly/6mpxyO
Adding Omega-3 to Margarine Doesn't Help Heart
webmd.com — “Margarine fortified with omega-3 fatty acids does not appear to protect older men and women who have survived a heart attack from having another heart attack or other cardiac event.” View full resource at webmd.com
Most Recently Shared on August 30, 2010 at 9:45 pm By:
webMD: Adding Omega-3 to Margarine Doesn't Help Heart http://bit.ly/d4J98N Full http://bit.ly/c7tfAR
Dynavax Initiates First Human Trial In Universal Flu Vaccine Program
medicalnewstoday.com — “Dynavax Technologies Corporation (NASDAQ: DVAX) announced the first human clinical trial in its Universal Flu vaccine program. The Phase 1 trial, which began vaccinating subjects in late June, wil” View full resource at medicalnewstoday.com
Most Recently Shared on July 8, 2010 at 2:06 pm By:
MNT Clinical Trials Health News
Dynavax Initiates First Human Trial In Universal Flu Vaccine Program http://mnt.to/3FQg #clinicaltrials
Abstract | Peripheral blood T Regulatory cell counts may not predict transplant rejection
biomedcentral.com — “Abstract | Peripheral blood T Regulatory cell counts may not predict transplant rejection” View full resource at biomedcentral.com
Most Recently Shared on July 16, 2010 at 10:58 am By:
Educator, Writer, Neuroscientist, Child and Adult psychiatrist, and is certified by the Nuclear Regulatory Commission for SPECT brain imaging. He specializes in advanced diagnostic and medical services for troubled children, adolescents and adults. His broad range of clinical experience from psychoanalysis to substance abuse, to psychopharmacology and SPECT neuroimaging, – and his experience with systems/functional medicine and biomedical assessments provides a comprehensive medical foundation for treatment interventions and recommendations. If you don't look, you can't see. At CorePsych mind/brain diagnosis evolves beyond the polemics of outdated categorical thinking driven by superficial labels. Virtual assessments available anywhere globally." /> Dr Charles Parker Active Health Library, Doctor, Psychiatrist, and Physician
#bmcimmunology Peripheral blood T Regulatory cell counts may not predict transplant rejection http://www.biomedcentral.com/1471-2172/11/40
Toxicity, Neuroleptic Agents: eMedicine Emergency Medicine
emedicine.medscape.com — “Overview: The neuroleptic agents are antipsychotic drugs that reduce confusion, delusions, hallucinations, and psychomotor agitation in patients with psychoses. The first-generation neuroleptic agents comprise a group of the following 7 classes of drugs: Phenothiazines, further divided into ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 4, 2010 at 1:15 am By:
Overdose of antipsychotic medication is more common among psychiatric patients than other individuals. http://bit.ly/aipfxc
Health care - msnbc.com
msnbc.msn.com — “Your guide to health care reform” View full resource at msnbc.msn.com
Most Recently Shared on September 3, 2009 at 1:36 pm By:
msnbc.com - Health Health News
Dose of reality: McCain ties to insurers? http://bit.ly/woyQ2
Colitis, Ulcerative on #MDlinx
mdlinx.com — “Colitis, Ulcerative on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 5, 2010 at 5:56 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Does Treatment Schedule Matter? Once Daily versus Divided Doses of 5-ASAs: Digestive Diseases http://bit.ly/dzyp6V #medicine
Oncology Article | Carcinoma, Non-Small-Cell Lung
mdlinx.com — “Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)” View full resource at mdlinx.com
Most Recently Shared on June 10, 2011 at 6:36 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily ... http://bit.ly/l6vqKA #oncology
Alzheimer's: Big Pharma Homes in on Vitamin and Supplement Market
thehealthierlife.co.uk — “The recent 'groundbreaking' Oxford study involved 168 volunteers all with brain shrinkage associated with 'mild cognitive impairment' (MCI)associated with the onset of Alzheimer's disease and dementia. Participants were divided into either a treatment group who were given a high dose of B vitamins (folic acid, B6 and B12) or a control group who were given a placebo.” View full resource at thehealthierlife.co.uk
Most Recently Shared on September 16, 2010 at 8:22 pm By:
Alzheimer's: Big Pharma Homes in on Vitamin and Supplement Market http://bit.ly/9w9Zfe
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
eHealthMe.com
eHealthMe provides health professionals and patients personalized tools to study millions of drug reports from FDA and community in real time.
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement
